Plantible | $30,000,000 | (Nov 19, 2024)
Theranautilus | $1,200,000 | (Nov 19, 2024)
Bluespine | $7,200,000 | (Nov 19, 2024)
Certified by Founder
Lodge
CanSense
start up
United Kingdom
- Swansea, Wales
- 09/03/2023
- Unknown
- $1,776,000
At CanSense we utilise cutting-edge data analytics and machine learning to maximise the performance of our blood test aimed at triaging patients at high risk of cancer.
- Industry Biotechnology Research
- Website https://cansenseltd.com/
- LinkedIn https://www.linkedin.com/company/cansense/
Zenflow, Inc. | $24,000,000 | (Nov 19, 2024)
Coopah | $1,901,280 | (Nov 19, 2024)
Revisto | $4,000,000 | (Nov 19, 2024)
ChapsVision | $90,000,000 | (Nov 19, 2024)
SuperAnnotate | $36,000,000 | (Nov 19, 2024)
IonKraft | $3,706,797 | (Nov 19, 2024)
ANELLO Photonics | Undisclosed Amount | (Nov 19, 2024)
Influur | $10,000,000 | (Nov 15, 2024)
Naturbeads | $9,890,632 | (Nov 15, 2024)